Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Apr 2, 2009

Premium

Proteros biostructures last week announced Dirk Ullmann has joined the company as chief scientific officer.

Ullmann will be responsible for developing the science base at the firm and for all ongoing client projects, the company said in a statement. Prior to joining Proteros, Ullmann was senior vice president for discovery biology for Evotec's service division.


New England Peptide this week said it named John Phipps to the newly created position of western region business development manager.

Phipps will be responsible for developing custom solutions for new customers. Prior to joining NEP, he was president of Biolink Solutions, which supplies customized bio-conjugation services to life science firms and hospital. Phipps also founded Global Peptide Services in 2001 and was its chief executive until 2007 when the company merged with Huntsville, Ala.-based Pi Proteomics.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.